연구동향 분석

ORIGINAL ARTICLE : Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study

( Byung Su Yoo ) ( Jin Joo Park ) ( Dong Ju Choi ) ( Seok Min Kang ) ( Juey Jen Hwang ) ( Shing Jong Lin ) ( Ming Shien Wen ) Jian Zhang ( Junbo Ge ) 2015년

논문상세정보
인용/피인용
' ORIGINAL ARTICLE : Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • eastasians
  • hospitalizedheartfailure
  • hyponatremia
  • predictor of clinical outcomes
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
25 0

0.0%

' ORIGINAL ARTICLE : Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study' 의 참고문헌

  • Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy
    Riegger GA Am J Cardiol 58 : 300 ~ 303 [1986]
  • Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
    Schrier RW N Engl J Med 355 : 2099 ~ 2112 [2006]
  • Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999
    Senni M J Card Fail 11 : 270 ~ 278 [2005]
  • Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry
    Gheorghiade M Eur Heart J 28 : 980 ~ 988 [2007]
  • Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure
    Packer M J Am Coll Cardiol 3 : 1035 ~ 1043 [1984]
  • Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure
    Lee WH Circulation 73 : 257 ~ 267 [1986]
  • Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
    Abraham WT J Am Coll Cardiol 52 : 347 ~ 356 [2008]
  • Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model
    Lee DS JAMA 290 : 2581 ~ 2587 [2003]
  • Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure
    Kearney MT J Am Coll Cardiol 40 : 1801 ~ 1808 [2002]
  • Osmotic and nonosmotic control of vasopressin release
    Schrier RW Am J Physiol 236 : F321 ~ F332 [1979]
  • Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction
    Udelson JE J Am Coll Cardiol 49 : 2151 ~ 2159 [2007]
  • Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion
    Schrier RW J Clin Invest 52 : 502 ~ 511 [1973]
  • Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure:results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
    Klein L Circulation 111 : 2454 ~ 2460 [2005]
  • Improvement of hyponatraemia during hospitalisation for acute heart failure is not associated with improvement of prognosis: an analysis from the Korean Heart Failure (KorHF) registry
    Lee SE Heart 98 : 1798 ~ 1804 [2012]
  • Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure
    Packer M J Am Coll Cardiol 10 : 837 ~ 844 [1987]
  • Hormones and hemodynamics in heart failure
    Schrier RW N Engl J Med 341 : 577 ~ 585 [1999]
  • Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial
    Gheorghiade M JAMA 291 : 1963 ~ 1971 [2004]
  • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial
    Konstam MA JAMA 297 : 1319 ~ 1331 [2007]
  • Characteristics, outcomes, and predictors of mortality at 3 months and 1year in patients hospitalized for acute heart failure
    Harjola VP Eur J Heart Fail 12 : 239 ~ 248 [2010]
  • Arginine vasopressin and the renal response to water loading in congestive heart failure
    Goldsmith SR Am J Cardiol 58 : 295 ~ 299 [1986]
  • 2009 focused update:ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation
    Jessup M Circulation 119 : 1977 ~ 2016 [2009]